Brief: Fusion Pharmaceuticals Says On April 30, 30-Day Statutory Waiting Period Under Competition Act Expired With Respect To Transaction With AstraZeneca AB
02/05/2024 13:05
May 2 (Reuters) - Fusion Pharmaceuticals Inc FUSN.O :
* FUSION PHARMACEUTICALS - ON APRIL 30, 30-DAY STATUTORY
WAITING
PERIOD UNDER COMPETITION ACT EXPIRED WITH RESPECT TO TRANSACTION
WITH ASTRAZENECA AB
Source text for Eikon: ID:n0001193125-24-128200
Further company coverage: FUSN.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Fusion Pharmaceuticals
See all newsBrief: Acquisition Of Fusion Pharmaceuticals Completed
Brief: Fusion Pharmaceuticals Receives Final Court Order Approving Arrangement
Brief: Fusion Pharmaceuticals Shareholders Approve Acquisition By Astrazeneca
Brief: Fusion Pharmaceuticals Shareholders Approve Acquisition By Astrazeneca
Fusion Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary